Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP300741.RAZAGIYcY54D6W9VJq-6VvdN4Hb80eYfl-iWlvjMtAbik130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300741.RAZAGIYcY54D6W9VJq-6VvdN4Hb80eYfl-iWlvjMtAbik130_provenance.
• assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1311872.RAazYx0Wjz1XPXl8IV89sz3I0PEN0BhL23qYf8R_OYgk0130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311872.RAazYx0Wjz1XPXl8IV89sz3I0PEN0BhL23qYf8R_OYgk0130_provenance.
• NP1311874.RAaxtLCS1BiT4msWrREU-8sL-LET4enCLRLD-iNq-Ykbg130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311874.RAaxtLCS1BiT4msWrREU-8sL-LET4enCLRLD-iNq-Ykbg130_provenance.
• NP1311875.RAD8c4ggn4sEmEq8-z4QFdLoMxMjFcdFUKhHRHLYwX0zY130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311875.RAD8c4ggn4sEmEq8-z4QFdLoMxMjFcdFUKhHRHLYwX0zY130_provenance.
• NP301093.RAvarU1ZrgjrCejoVWV1Al5TbFbFXali70f1ZPwKx_l8k130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301093.RAvarU1ZrgjrCejoVWV1Al5TbFbFXali70f1ZPwKx_l8k130_provenance.
• NP1311871.RAviohVWx3OAO_DXO0INT4VQiCpjt2hU7C3L1-giP4Eio130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311871.RAviohVWx3OAO_DXO0INT4VQiCpjt2hU7C3L1-giP4Eio130_provenance.
• NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311873.RApzgC5bLr1hf8FGoxSCmauV-RdMN2p_wxynA5ZGg4f18130_provenance.
• NP300763.RAz_mUExrzkZ1cWstLinMhhWdyL1t-HLU4iedrZAaoFN4130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300763.RAz_mUExrzkZ1cWstLinMhhWdyL1t-HLU4iedrZAaoFN4130_provenance.
• NP300947.RA_e8v62MD_zOFC11W1VJ21eP94zy0pgtVsMzMPFlj2E4130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300947.RA_e8v62MD_zOFC11W1VJ21eP94zy0pgtVsMzMPFlj2E4130_provenance.
• NP300756.RAKeyGQOn-bNBtJmZ9MXhTJ3tS6lLmY8UOt9H3P4uSulQ130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300756.RAKeyGQOn-bNBtJmZ9MXhTJ3tS6lLmY8UOt9H3P4uSulQ130_provenance.
• NP306067.RAOGqo8fdHCqOa06i6BD-6pSShdXpIyJuadrckUk_CjQQ130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306067.RAOGqo8fdHCqOa06i6BD-6pSShdXpIyJuadrckUk_CjQQ130_provenance.
• NP1311869.RAJ81o-z_15nQeDsB0sAR0H7uPwUiPx8ePbQAi5O_WceY130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311869.RAJ81o-z_15nQeDsB0sAR0H7uPwUiPx8ePbQAi5O_WceY130_provenance.
• NP1311870.RAOaUmG5fNYshxdCtmAqbuJzRevJJGQjL_m97wBrAr_tU130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311870.RAOaUmG5fNYshxdCtmAqbuJzRevJJGQjL_m97wBrAr_tU130_provenance.
• NP1311877.RANIHYtTmuqmpKIQ2WSNiKfF7xskpQIQf-zPiaZQ6WgtU130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311877.RANIHYtTmuqmpKIQ2WSNiKfF7xskpQIQf-zPiaZQ6WgtU130_provenance.
• NP1311868.RAxpSqlrfxkMsAZJBY_DsPgOS52-tEsVEWcknQlLu6BUI130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311868.RAxpSqlrfxkMsAZJBY_DsPgOS52-tEsVEWcknQlLu6BUI130_provenance.
• NP1311878.RA13ydySumlFjIo1-95F8s7x4iigVwjrR9We8zxA0w3RY130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311878.RA13ydySumlFjIo1-95F8s7x4iigVwjrR9We8zxA0w3RY130_provenance.
• NP1311879.RA4sCpvcgolxhQrDHEKZhl80XkqztdnksQZ9ZpC97dhAc130_assertion description "[To determine if CDKN2 or another closely related gene on 9p is the target of 9p deletions in ALL and other hematologic malignancies, we analyzed 20 primary patient samples (13 ALL, 2 acute myeloid leukemias [AML], and 5 non-Hodgkin's lymphomas [NHL]) with 9p rearrangements using Southern blot analysis, fluorescence in situ hybridization (FISH), and single-strand conformation polymorphism (SSCP) for alterations of CDKN2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311879.RA4sCpvcgolxhQrDHEKZhl80XkqztdnksQZ9ZpC97dhAc130_provenance.